Apceth GmbH und Co. KG

Activities: Manufacturing Research & Development Pharmaceutical

Trending Articles

  1. OINDPs: Nosey about recent developments? OINDPs are a user friendly and efficacious alternative to injectables in several disease areas
  2. Transforming healthcare with patient centricity In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
  3. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  4. Compact process thermostat for efficient temperature control in the laboratory The temperature control system is designed for the accurate temperature control of small research reactors between -40 to +200 °C
  5. AviadoBio expands presence at Canary Wharf The company has acquired 11,000 sqft of laboratory and office space in Canary Wharf to accommodate the growing team

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Ingredients

Refined commercial production spec gets gene therapy EMA go-ahead

US-based Bluebird Bio is working with German apceth Biopharma for commercial manufacturing of its one-time thalassemia therapy that is approved in the EU, not the US
Regulatory

Apceth bullish on manufacturing deal with bluebird bio

The German CDMO will operate as commercial manufacturer in Europe for Zynteglo, bluebird bio's first gene therapy to gain regulatory approval
Finance

Hitachi buys all Acpeth Biopharma shares

Apceth Biopharma now becomes Hitachi's new European hub for cell therapy
Manufacturing

apceth Biopharma Appoints Dusan Kosijer as Chief Financial Officer
Research & Development

apceth and University of Cologne join forces on immunotherapies for cancer

The collaboration is based on combinations of chimeric antigen receptor (CAR) T cells and apceth-developed engineered mesenchymal stem cells
Research & Development

Apceth expands senior management team

Ulrike Verzetnitsch joins the company as Chief Technical Officer
Research & Development

Apceth names Stefanos Theoharis as Chief Business Officer

He will lead Apceth’s business development
Subscribe now